Edwards Lifesciences announced today that its Sapien M3 mitral valve replacement system received FDA approval for mitral ...

Edwards Lifesciences EW announced that the FDA approved its SAPIEN M3 transcatheter mitral valve replacement system, making ...

The US Food and Drug Administration has approved the Sapien M3 system for transseptal transcatheter mitral valve replacement (TMVR) for use in patients with symptomatic moderate-to-severe mitral ...

Edwards Lifesciences has claimed an FDA approval for its Sapien M3 transcatheter mitral valve replacement system—marking the ...

The Sapien M3 device is the first approved mitral regurgitation treatment to use a transseptal approach, Edwards said.

Dublin, Oct. 27, 2020 (GLOBE NEWSWIRE) -- The "Transseptal Needle Market Insights 2020 - Analysis and Forecasts for the Global and Chinese Markets to 2025, by Manufacturers, Regions, Technology, ...

First-of-its-kind Edwards SAPIEN M3 transcatheter mitral valve system secures FDA approval for transseptal mitral ...

Please provide your email address to receive an email when new articles are posted on . A transseptal mitral valve replacement system was approved for patients unsuitable for surgery or transcatheter ...

SAN FRANCISCO, CA—Transcatheter mitral valve-in-valve procedures, especially those done via transseptal access, are associated with low mortality and adverse event rates as well as quality-of-life ...

Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — Among patients who underwent transcatheter valve-in-valve repair of a failed surgical mitral ...

Cook Medical recalled all unexpired lots of Transseptal Needles and Transseptal Needles with Catheter, used in heart procedures and made over a nearly five-year period, after customers found rust on ...

BLOOMINGTON, Ind.--(BUSINESS WIRE)--Cook Medical issued a global, voluntary recall of the Transseptal Needle and the Transseptal Needle with Catheter. This recall includes all unexpired lots for both ...